SCRI - Tennessee Oncology

12140 Nall Avenue
Overland Park, Kansas 66209

We've found

1 trials

at this facility

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Overland Park, KS

Use our guide to learn which trials are right for you!